Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma

BACKGROUND: Pancreatic adenocarcinoma (PAAD) is one of the deadliest types of cancer. In the early stages, patients often have atypical symptoms, making diagnosis difficult. The prognosis of diagnosed patients is very poor and treating PAAD is challenging. Therefore, determining reliable risk factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Lin, Zhang, Gerui, Wu, Taihua, Wu, Guangzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Database Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611937/
https://www.ncbi.nlm.nih.gov/pubmed/34799547
http://dx.doi.org/10.12659/MSM.933443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611937/
https://www.ncbi.nlm.nih.gov/pubmed/34799547
http://dx.doi.org/10.12659/MSM.933443

Ejemplares similares